5 Best One Dollar Stocks To Buy Now
In this article, we discuss the 5 best one dollar stocks to buy today.
Harpoon Therapeutics Inc. (HARP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 0 | $0 | -100% | 0% |
| 2. | BioImpact Capital Mpm Capital | 0 | $0 | -100% | 0% |
| 3. | Millennium Management Israel Englander | 0 | $0 | -100% | 0% |
| 4. | Commodore Capital Egen Atkinson And Michael Kramarz | 0 | $0 | -100% | 0% |
| 5. | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.00 | 21,397,205 | 1,000 | 2024-03-11 | Filing | ||
| $0.00 | 171,500 | Large Shareholder | 395,783 | 2023-10-25 | Filing | |
| $0.00 | 1,372,000 | Large Shareholder | 1,463,386 | 2023-10-25 | Filing | |
| $0.00 | 171,500 | Large Shareholder, Director | 395,783 | 2023-10-25 | Filing | |
| $0.00 | 1,372,000 | Large Shareholder, Director | 1,463,386 | 2023-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.50 | 25,118 | Large Shareholder | 6,328,095 | 2021-06-02 | Filing | |
| $20.44 | 18,491 | Large Shareholder | 6,353,213 | 2021-06-01 | Filing | |
| $22.60 | 100 | Large Shareholder | 6,371,704 | 2021-05-28 | Filing | |
| $21.92 | 3,100 | Large Shareholder | 6,371,804 | 2021-05-28 | Filing | |
| $20.88 | 10,685 | Large Shareholder | 6,374,904 | 2021-05-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,859,168 | $21,138,740 | 17.02% | |
| 2. | 1,492,368 | $16,968,224 | 0% | |
| 3. | 880,017 | $10,005,794 | 0% | |
| 4. | 815,000 | $9,266,550 | 0.04% | |
| 5. | 428,400 | $4,870,908 | 2.9% |
News See All
5 Stocks Gaining Ground on Tuesday
In this article, we take a look at five stocks that are gaining ground on Tuesday.
Were Hedge Funds Right About Harpoon Therapeutics, Inc. (HARP)?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second ...
Where Do Hedge Funds Stand On Harpoon Therapeutics, Inc. (HARP)?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Hedge Funds Are Warming Up To Harpoon Therapeutics, Inc. (HARP)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Hedge Fund and Insider Trading News: Bill Miller, Seth Klarman, Ken Griffin, Jim Simons, Blue Ridge Capital, Phillips 66 Partners LP (PSXP), PNC Financial Services Group Inc (PNC), and More
Legendary investor Bill Miller’s hedge fund jumped 120% last year -- and he says it’s because he didn’t stray from his top names.
Hedge Funds Have Never Been This Bullish On Harpoon Therapeutics, Inc. (HARP)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Harpoon Therapeutics, Inc. (HARP): Hedge Funds In Wait-and-See Mode
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.